ArticleJCO precision oncology2022

Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit.

Romualdo Barroso-Sousa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.